Explain the mechanism of acute respiratory distress syndrome

Reading File

search_medical_text

ARDS acute respiratory distress syndrome pathophysiology mechanism

search_medical_text

ARDS diffuse alveolar damage phases exudative proliferative fibrotic

GradeResponse

search_medical_text

ARDS exudative phase neutrophil cytokine alveolar epithelial injury pulmonary edema

search_medical_image

ARDS pathophysiology diffuse alveolar damage mechanism diagram

GradeResponse

Acute Respiratory Distress Syndrome (ARDS): Mechanism

Definition and Core Pathophysiologic Features

ARDS is a syndrome defined by three cardinal pathophysiologic features (ARDS Definition Guidelines, p. 2):

Increased alveolo-capillary membrane permeability → inflammatory (non-cardiogenic) pulmonary edema
Increased non-aerated lung tissue → reduced lung compliance (higher elastance)
Increased venous admixture and dead space → hypoxemia (low PaO₂/FiO₂ ratio) and hypercapnia

Initiating Triggers

ARDS arises from either direct (pulmonary) or indirect (extrapulmonary) insults:

Direct	Indirect
Pneumonia (bacterial, viral, fungal)	Sepsis
Aspiration of gastric contents	Severe trauma / shock
Pulmonary contusion	Pancreatitis
Inhalation injury	Massive transfusion (TRALI)
Near-drowning	Burns

The Three Phases of ARDS

Harrison's Principles of Internal Medicine (p. 8196) describes a natural history of three overlapping phases, each with distinct cellular and structural features:

Phase 1 — Exudative Phase (Days 1–7)

This is the dominant inflammatory phase:

Initial insult activates alveolar macrophages, which release pro-inflammatory cytokines: TNF-α, IL-1β, IL-6, IL-8.
These cytokines recruit neutrophils from the pulmonary capillaries into the alveolar space.
Activated neutrophils release:
- Reactive oxygen species (ROS)
- Proteases (elastase, matrix metalloproteinases)
- Myeloperoxidase (MPO)
- Neutrophil extracellular traps (NETs)
This toxic arsenal directly injures the alveolar epithelium (type I pneumocytes) and vascular endothelium.

Consequences of epithelial and endothelial injury:

Loss of tight junctions → protein-rich fluid floods the alveolar space (non-cardiogenic pulmonary edema)
Destruction of type II pneumocytes → impaired surfactant production → alveolar collapse (atelectasis)
Formation of hyaline membranes (fibrin + cellular debris lining the denuded alveoli) — the histologic hallmark of diffuse alveolar damage (DAD)
Platelet-neutrophil complexes (via P-selectin/PSGL-1 interactions) amplify microvascular injury

Physiologic result: Flooded, collapsed alveoli create intrapulmonary shunt → refractory hypoxemia. The non-aerated but perfused lung units are unresponsive to supplemental oxygen alone.

ARDS cellular and molecular mechanisms diagram

ARDS pathophysiology: viral/inflammatory activation of macrophages and neutrophils leading to diffuse alveolar damage and hyaline membrane formation

Phase 2 — Proliferative Phase (Days 7–21)

If the patient survives:

Type II pneumocytes proliferate to resurface the denuded alveolar epithelium and differentiate into type I cells.
Inflammation begins to resolve; macrophage phenotype shifts toward anti-inflammatory (M2).
Fibroblast migration and proliferation begins — early fibroproliferation.
Edema fluid is reabsorbed as the epithelial barrier is restored.

Most patients improve during this phase, though lung mechanics remain abnormal.

Phase 3 — Fibrotic Phase (Weeks to Months)

A subset of patients progress to:

Extensive fibrosis of the alveolar walls, interstitium, and airspaces
Architectural distortion of lung parenchyma
Obliteration of the pulmonary microvasculature → pulmonary hypertension
Cystic changes and a "honeycomb" pattern on imaging
Persistent dead space ventilation → hypercapnia and ventilator dependence

The stimulus for fibrosis appears to be sustained TGF-β signaling and disordered repair. This phase carries the highest mortality and longest ICU course.

Key Molecular Mediators Summary

Mediator	Source	Effect
TNF-α, IL-1β, IL-6	Macrophages	Neutrophil recruitment, systemic inflammation
IL-8 (CXCL8)	Epithelium, macrophages	Potent neutrophil chemoattractant
ROS, MPO	Neutrophils	Direct oxidative tissue injury
NETs	Neutrophils	Endothelial/epithelial damage, thrombosis
TGF-β	Multiple	Fibroproliferation, impaired epithelial repair
Surfactant deficit	Injured type II cells	Alveolar collapse, reduced compliance

Physiologic Consequences

Reduced PaO₂/FiO₂ ratio (Berlin criteria: <300 mmHg with PEEP ≥5 cmH₂O)
Reduced lung compliance — "stiff lungs" requiring high airway pressures
Intrapulmonary shunting — perfusion of non-ventilated alveoli
Increased dead space — ventilation of non-perfused units → CO₂ retention
Pulmonary hypertension — hypoxic vasoconstriction + vascular remodeling → right ventricular strain

Summary

ARDS is fundamentally a syndrome of uncontrolled innate immune activation causing diffuse alveolar damage. The inciting insult — whether pulmonary or systemic — activates macrophages and recruits neutrophils, whose cytotoxic arsenal destroys the alveolo-capillary barrier. The result is flooding of alveoli with protein-rich edema, loss of surfactant, and refractory hypoxemia. Recovery depends on the balance between further injury and epithelial repair; fibroproliferation in a subset leads to irreversible lung remodeling.

This is a shared conversation. Sign in to Orris to start your own chat.